Back to screener
Showing saved data while refreshing the latest quote and financials…
Bafna Pharmaceuticals Limited
₹317.20
▲ 6.20 (+1.99%) today
Saved quote · Yahoo Finance
Market Cap
₹750 Cr
P/E (TTM)
96.1
P/B
7.8
Book Value
₹40.57
ROE
8.1%
Div Yield
—
D/E
0.39
EPS (TTM)
₹3.30
52W High
₹318.50
52W Low
₹94.77
Sales Growth
-23.20%
Profit Growth
-97.90%
Fundamentals refreshed 14 hr ago · Statements — · Source: Yahoo Finance
Quick Take
- • Trading at 96.1× trailing earnings
- • Moderate ROE at 8.1%
- • Low leverage (D/E 0.39)
- • No dividend data
- • Operating margin -3.4% · Net margin 5.5%
- • Profit growth -97.90% YoY · Beta 0.10
Employees: 339
Loading shareholding pattern…
Who is buying / selling · last 12 months (NSE)
| Date | Party | Type | Side | Qty | Price |
|---|---|---|---|---|---|
| 6 Aug 26 | Cullinan Opprts Fund Vcc-Cullinan Opportunities Incorporated Vcc Sub Fund 1 | Bulk deal | BUY | 6,66,000 | ₹284.55 |
| 6 Aug 26 | M7 Global Fund Pcc-Aerion | Bulk deal | SELL | 6,66,000 | ₹284.55 |
About the company
From latest AR & concall Reading the latest annual report and earnings call… (1–3 min on first visit)
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company offers its products in various dosage forms, including tablets, capsules, and solid orals. It provides various products for cardiovascular and hypertension, potent oncology, anti-infectives, central nervous system, and diabetic related diseases, as well as provision of contract research and manufacturing services. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, and Nigeria. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. The company operates as a subsidiary of SRJR Lifesciences LLP.
